Humanized antibodies that recognize beta amyloid peptide

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9051363
APP PUB NO 20090069544A1
SERIAL NO

11842042

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of Aβ in the brain of a patient. Preferred agents include humanized antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • JANSSEN SCIENCES IRELAND UC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Basi, Guriq Palo Alto, US 17 1036
Saldanha, Jose William Enfield, GB 34 1407
Schenk, Dale B Burlingame, US 133 5594

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 9, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00